Literature DB >> 10639332

Developmentally regulated activity of CRM1/XPO1 during early Xenopus embryogenesis.

M Callanan1, N Kudo, S Gout, M Brocard, M Yoshida, S Dimitrov, S Khochbin.   

Abstract

In this work, we have investigated the role of CRM1/XPO1, a protein involved in specific export of proteins and RNA from the nucleus, in early Xenopus embryogenesis. The cloning of the Xenopus laevis CRM1, XCRM1, revealed remarkable conservation of the protein during evolution (96.7% amino acid identity between Xenopus and human). The protein and mRNA are maternally expressed and are present during early embryogenesis. However, our data show that the activity of the protein is developmentally regulated. Embryonic development is insensitive to leptomycin B, a specific inhibitor of CRM1, until the neurula stage. Moreover, the nuclear localization of CRM1 changes concomitantly with the appearance of the leptomycin B sensitivity. These data suggest that CRM1, present initially in an inactive form, becomes functional before the initiation of the neurula stage during gastrula-neurula transition, a period known to correspond to a critical transition in the pattern of gene expression. Finally, we confirmed the gastrula-neurula transition-dependent activation of CRM1 by pull-down experiments as well as by the study of the intracellular localization of a green fluorescent protein tagged with a nuclear export signal motif during early development. This work showed that the regulated activity of CRM1 controls specific transitions during normal development and thus might be a key regulator of early embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639332     DOI: 10.1242/jcs.113.3.451

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Traffic control at the nuclear pore.

Authors:  Mohamed Kodiha; Noah Crampton; Sanhita Shrivastava; Rehan Umar; Ursula Stochaj
Journal:  Nucleus       Date:  2010-02-08       Impact factor: 4.197

3.  Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways.

Authors:  D Seigneurin-Berny; A Verdel; S Curtet; C Lemercier; J Garin; S Rousseaux; S Khochbin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Cortisol safeguards oogenesis by promoting follicular cell survival.

Authors:  Hesheng Xiao; Zhen Xu; Xi Zhu; Jingrong Wang; Qiaoyuan Zheng; Qingqing Zhang; Chunmei Xu; Wenjing Tao; Deshou Wang
Journal:  Sci China Life Sci       Date:  2022-02-11       Impact factor: 10.372

5.  Visualizing Nuclear Pore Complexes in Xenopus Egg Extracts.

Authors:  Sampada Mishra; Daniel L Levy
Journal:  Methods Mol Biol       Date:  2022

6.  Maternal gene expression in Atlantic halibut (Hippoglossus hippoglossus L.) and its relation to egg quality.

Authors:  Maren Mommens; Jorge Mo Fernandes; Teshome T Bizuayehu; Sylvie L Bolla; Ian A Johnston; Igor Babiak
Journal:  BMC Res Notes       Date:  2010-05-24

7.  Generation of stable Xenopus laevis transgenic lines expressing a transgene controlled by weak promoters.

Authors:  Anne L'hostis-Guidet; Gaëlle Recher; Brigitte Guillet; Abdulrahim Al-Mohammad; Pascal Coumailleau; François Tiaho; Daniel Boujard; Thierry Madigou
Journal:  Transgenic Res       Date:  2009-04-30       Impact factor: 2.788

8.  Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner.

Authors:  Ryo Takayanagi; Takashi Ohashi; Eizaburo Yamashita; Yohei Kurosaki; Kumiko Tanaka; Yoshiyuki Hakata; Yasumasa Komoda; Satoru Ikeda; Yasuko Tsunetsugu-Yokota; Yuetsu Tanaka; Hisatoshi Shida
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 9.  Nuclear Export Inhibition for Pancreatic Cancer Therapy.

Authors:  Irfana Muqbil; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2018-05-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.